Home / Companies / Results / Biocon Q1 pre-tax profit declines 21% to Rs 252.30 crore, revenue up 14%

Biocon Q1 pre-tax profit declines 21% to Rs 252.30 crore, revenue up 14%

High R&D spend, low profitability in research services due to Covid-19 pull down net profit

Premium

The net profit for the period declined 26 per cent to Rs 167.8 crore on YoY basis, according to a BSE filing by the company

Samreen Ahmad Bengaluru

2 min read Last Updated : Jul 24 2020 | 2:37 AM IST

Biotechnology major Biocon on Friday posted a profit before tax (PBT) of Rs 252.30 crore for the first quarter of FY21, a decline of 21 per cent when compared with the corresponding quarter of previous financial year.

The net profit for the period declined 26 per cent to Rs 167.8 crore on YoY basis, according to a BSE filing by the company. The company’s revenue however saw a double-digit growth of 13.9 per cent as compared to Q1 of FY20 driven by growth in biosimilars and generics segments.

“Profitability for the quarter was impacted due to higher R&D spend, lower

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in